CREYON
Live / Registered — Registered (as of 12 May 2026)
What this means for you
Registered since 12 May 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 May 2032: the §8 declaration of use).
Record
- Serial number
- 90846005
- Registration number
- 8253859
- Mark type
- Word mark
- Filed
- 23 Jul 2021
- Published for opposition
- 24 Jan 2023
- Registered
- 12 May 2026
- Next maintenance filing
- §8 declaration of use, due by 12 May 2032 (grace period to 12 Nov 2032)
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research in the field of Oligonucleotide-Based Medicines; Oligonucleotide-Based drug development services; engineering and chemical synthesis of oligonucleotide-based medicines and their building blocks and delivery technologies; engineering and chemical synthesis of oligonucleotide therapeutics and their building blocks and delivery technologies; experimental assessment of pharmacological and chemical properties of oligonucleotide-base medicines in the nature of pharmaceutical research and development
Owner
- Creyon Bio, Inc., San Diego, CA, US
- Creyon Bio, Inc., San Diego, CA, US
- Creyon Bio, Inc., San Diego, CA, US
Prosecution history
- 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 May 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 May 2026 — REGISTERED-PRINCIPAL REGISTER
- 22 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Mar 2026 — USE AMENDMENT FILED
- 23 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 06 Feb 2026 — SOU EXTENSION 5 GRANTED
- 17 Sept 2025 — SOU EXTENSION 5 FILED
- 06 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2025 — SOU EXTENSION 4 GRANTED
- 14 Mar 2025 — SOU EXTENSION 4 FILED